US health care utilization and costs in adult patients with atopic dermatitis by disease severity

por Wang, Xin, Boytsov, Natalie N, Gorritz, Magdaliz, Malatestinic, William N, Goldblum, Orin M, Wade, Rolin L
Publicado 2022

Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey

por Orbai, Ana-Maria, Birt, Julie A., Holdsworth, Elizabeth A., Booth, Nicola, Malatestinic, William N., Sprabery, Aubrey T., Reginato, Anthony M.
Publicado 2020

Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program

por Gottlieb, Alice B., Burge, Russel, Malatestinic, William N., Zhu, Baojin, Zhao, Yunyang, McCormack, Julie, Kimel, Miriam, Merola, Joseph F.
Publicado 2023

Employment, Work Productivity, and Biologic Treatments in Self-Reported Axial Spondyloarthritis: a Cross-Sectional Study in a Female Predominant Population from the ArthritisPower...

por Gavigan, Kelly, Nowell, W. Benjamin, Hunter, Theresa, Curtis, Jeffrey R., Malatestinic, William N., Bolce, Rebecca J., Lisse, Jeffrey R., Walsh, Jessica
Publicado 2022

Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan(®) Databases

por Leonardi, Craig, Zhu, Baojin, Malatestinic, William N., Eastman, William J., Guo, Jiaying, Murage, Mwangi J., Choong, Casey Kar-Chan, Burge, Russel, Blauvelt, Andrew
Publicado 2022

Treatment Satisfaction and Decision‐making from the Patient Perspective in Axial Spondyloarthritis: Real‐World Data from a Descriptive Cross‐sectional Survey Study from the Arthrit...

por Nowell, William Benjamin, Gavigan, Kelly, Hunter, Theresa, Malatestinic, William N., Bolce, Rebecca J., Lisse, Jeffrey R., Himelein, Carol, Curtis, Jeffrey R., Walsh, Jessica A.
Publicado 2021

Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs

por Murage, Mwangi J, Princic, Nicole, Park, Julie, Malatestinic, William N, Zhu, Baojin, Atiya, Bilal, Kern, Scott A, Stenger, Keri B, Sprabery, Aubrey Trevelin, Ogdie, Alexis
Publicado 2022

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab

por Blauvelt, Andrew, Shi, Nianwen, Burge, Russel, Malatestinic, William N, Lin, Chen-Yen, Lew, Carolyn R, Zimmerman, Nicole M, Goldblum, Orin M, Zhu, Baojin, Murage, Mwangi J
Publicado 2020

Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry

por Lockshin, Benjamin, Harrison, Ryan W., McLean, Robert R., Crabtree, Margaux M., Konicek, Bruce W., Zhu, Baojin, Malatestinic, William N., Atiya, Bilal, Murage, Mwangi J., Burge, Russel T.
Publicado 2022

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

por Murage, Mwangi J, Tongbram, Vanita, Feldman, Steven R, Malatestinic, William N, Larmore, Cynthia J, Muram, Talia M, Burge, Russel T, Bay, Charles, Johnson, Nicole, Clifford, Sarah, Araujo, Andre B
Publicado 2018

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry

por Mease, Philip J, Etzel, Carol J, Huster, William J, Muram, Talia M, Armstrong, April W, Lisse, Jeffrey R, Rebello, Sabrina, Dodge, Rhiannon, Murage, Mwangi James, Greenberg, Jeffrey D, Malatestinic, William N
Publicado 2019

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry

por Lockshin, Benjamin, Cronin, Angel, Harrison, Ryan W., McLean, Robert R., Anatale‐Tardiff, Laura, Burge, Russel, Zhu, Baojin, Malatestinic, William N., Atiya, Bilal, Murage, Mwangi J., Gallo, Gaia, Strober, Bruce, Van Voorhees, Abby
Publicado 2021